Calcitonin Gene-Related Peptide (CGRP) Receptor Antagonists in the Treatment of Migraine

ISSN： 1172-7047

Source： CNS Drugs, Vol.24, Iss.7, 2010-07, pp. : 539-548

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Calcitonin gene-related peptide receptor antagonists for migraine

By Fischer Michael JM

Expert Opinion on Investigational Drugs, Vol. 19, Iss. 7, 2010-07 ,pp. : 815-823

Informa Healthcare

Access to resources Recommend Favorite

Calcitonin Gene-Related Peptide Antagonists as Treatments of Migraine and Other Primary Headaches

By Goadsby Peter J.

Drugs, Vol. 65, Iss. 18, 2005-01 ,pp. : 2557-2567

Adis International

Access to resources Recommend Favorite

Calcitonin Gene-Related Peptide (CGRP) and the Pathophysiology of Headache: Therapeutic Implications

By Edvinsson L.

CNS Drugs, Vol. 15, Iss. 10, 2001-01 ,pp. : 745-753

Adis International

Access to resources Recommend Favorite

Modelling the Anti-Migraine Effects of BIBN 4096 BS: A New Calcitonin Gene-Related Peptide Receptor Antagonist

By Trocóniz Iñaki F.

Clinical Pharmacokinetics, Vol. 45, Iss. 7, 2006-01 ,pp. : 715-728

Adis International

Access to resources Recommend Favorite

Discovery techniques for calcitonin gene-related peptide receptor antagonists for potential antimigraine therapies

By Labruijere Sieneke Ibrahimi Khatera Chan Kayi Y MaassenVanDenBrink Antoinette

Expert Opinion on Drug Discovery, Vol. 8, Iss. 11, 2013-11 ,pp. : 1309-1323

Informa Healthcare

Access to resources Recommend Favorite